Apellis Pharmaceuticals, Inc.
VIRAL VECTOR THERAPY
Last updated:
Abstract:
Methods and compositions for combined therapy with viral vectors and complement inhibitors are described.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2020
Issue date:
11 Aug 2022